The risk of new-onset type 2 diabetes and coronary heart disease in chronic schizophrenic patients treated with aripiprazole and olanzapine

被引:5
作者
Blonde, L
Ray, S
Corey-Lisle, R
Cislo, PR
L'Italien, G
机构
[1] Alton Ochsner Med Fdn & Ochsner Clin, Endocrinol Sect, New Orleans, LA 70121 USA
[2] Bristol Myers Squibb Co, Wallingford, CT 06492 USA
关键词
D O I
10.1016/S0924-977X(04)80317-1
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:S275 / S275
页数:1
相关论文
共 3 条
[2]  
LITALIEN G, 2004, AM PSYCH ASS ANN M 1
[3]   Adverse metabolic effects associated with atypical antipsychotics - Literature review and clinical implications [J].
Melkersson, K ;
Dahl, ML .
DRUGS, 2004, 64 (07) :701-723